1,2-Dichloroethane → (R)-N-(5-(4-(5-(2-(3-fluorophenyl)acetamido)-1,3,4-thiadiazol-2-yl)butyl)-1,3,4-thiadiazol-2-yl)-3,4-dihydroxybutanamide
Reaction equation
[CH2:1]([C:11]1[S:15][C:14]([NH2:16])=[N:13][N:12]=1)[CH2:2][CH2:3][CH2:4][C:5]1[S:9][C:8]([NH2:10])=[N:7][N:6]=1.[F:17][C:18]1[CH:19]=[C:20]([CH2:24][C:25]([OH:27])=O)[CH:21]=[CH:22][CH:23]=1.CC1(C)[O:33][C@H:32]([CH2:34][C:35](O)=[O:36])[C:31](=O)[O:30]1.C1C=CC2N(O)N=NC=2C=1.C(Cl)CCl>CN(C=O)C.O.CCN(CC)CC>[F:17][C:18]1[CH:19]=[C:20]([CH2:24][C:25]([NH:10][C:8]2[S:9][C:5]([CH2:4][CH2:3][CH2:2][CH2:1][C:11]3[S:15][C:14]([NH:16][C:35](=[O:36])[CH2:34][C@@H:32]([OH:33])[CH2:31][OH:30])=[N:13][N:12]=3)=[N:6][N:7]=2)=[O:27])[CH:21]=[CH:22][CH:23]=1Participants
Reactant 5
Product 1
Reagents, catalysts & solvents 3
Procedure
To a suspension of diamine 1001 (400 mg, 1.56 mmol), 3-fluorophenylacetic acid (313 mg, 2.03 mmol), (R)-(−)-2,2-dimethyl-5-oxo-1,3-dioxolane-4-acetic acid (353 mg, 2.03 mmol) and Et3N (200 μL) in DMF (20 mL) at 0° C. was added HOBt (633 mg, 4.68 mmol) and followed by EDC (897 mg, 4.68 mmol). The mixture was stirred from 0° C. to room temperature over 18 h before it was diluted with water. The precipitate was collected by suction filtration and washed with water. The solid was further rinsed with a mixture of hot MeOH-THF. The combined filtrate was concentrated and purified by silica gel chromatography eluting with 1-10% MeOH in CH2Cl2 to provide (R)—N-(5-(4-(5-(2-(3-fluorophenyl)acetamido)-1,3,4-thiadiazol-2-yl)butyl)-1,3,4-thiadiazol-2-yl)-3,4-dihydroxybutanamide (1013, 93 mg).
Workup
- filtrationThe precipitate was collected by suction filtration
- washwashed with water
- washThe solid was further rinsed with a mixture of hot MeOH-THF
- concentrationThe combined filtrate was concentrated
- custompurified by silica gel chromatography
- washeluting with 1-10% MeOH in CH2Cl2
Sources & evidence
- ORD record
- ord-11571c8796a4498d9e10c58d3d7ae7a2
- Source dataset
- uspto-grants-2014_10
- Patent number
- US08865718B2
Reaction notes
Loading…